AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 35964947
Drug: Low-flow anesthesia
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-flow anesthesia (Group L) in smokers
Trial: 32546490
Drug: Amoxicillin (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (750 mg three times daily for 100 days)
Trial: 36498611
Drug: RA.DI.CA splint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RA.DI.CA splint therapy
Trial: 37711718
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg of caffeine
Trial: 35366092
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg of cellulose (placebo)
Trial: 36123011
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg once daily for 24 months
Trial: 32354234
Drug: Cognitive Flexibility
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Flexibility in Aphasia Therapy (CFAT)
Trial: 36250371
Drug: Probiotic treatment
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic treatment (multi-strain probiotics including Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium breve, Bifidobacterium lactis, Bifidobacterium longum, Streptococcus thermophilus) for 8 weeks.
Trial: 36037565
Drug: Chewing gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewing gum containing 700 mg xylitol (CG)
Trial: 36856614
Drug: Hydrochlorothiazide 50
RxNorm normalized name: hydrochlorothiazide 50 MG
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 50 mg once daily
Trial: 36457207
Drug: Innovator brand
RxNorm normalized name: Eagle Brand Medicated Oil
DrugBank: Eucalyptus oil (DB11114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Innovator brand itraconazole 100 mg twice a day for 4 weeks
Trial: 33709937
Drug: Web-based therapist-supported
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based therapist-supported cognitive behavioral therapy (Heart RCT)
Trial: 33764654
Drug: Low-dose dexamethasone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dexamethasone (0.25 mg/kg/dose)
Trial: 33764654
Drug: High-dose dexamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose dexamethasone (0.5 mg/kg/dose)
Trial: 35696440
Drug: Multicomponent intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multicomponent intervention including physician training in risk-based treatment, subsidized losartan-HCTZ single-pill combination medications, nurse training in motivational conversations, and telephone follow-ups.
Trial: 33009489
Drug: Enzalutamide -
RxNorm normalized name: Enzalutamide
DrugBank: Enzalutamide (DB08899)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Enzalutamide - 160 mg/day
Trial: 36342811
Drug: Lianhua Qingwen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lianhua Qingwen capsule (LH), 4 capsules, thrice daily for 14 days
Trial: 32646266
Drug: Pharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological treatment (Texas Medication Algorithm Project)
Trial: 32907282
Drug: Anti-HBs <2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-HBs <2.5 mIU/ml
Trial: 33836974
Drug: Palbociclib (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palbociclib (150 mg on days 5 to 18) and T-DM1 (day 1 intravenous) in 21-day treatment cycles
Trial: 38458371
Drug: Ticagrelor monotherapy
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticagrelor monotherapy
Trial: 34000088
Drug: Conventional dual-antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dual-antiplatelet therapy (DAPT)
Trial: 38838501
Drug: First-line chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: First-line chemotherapy
Trial: 33357070
Drug: Taurine (50 mg·kg‐1)
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine (50 mg·kg‐1)
Trial: 33610734
Drug: zolbetuximab +
RxNorm normalized name: Zolbetuximab
DrugBank: Zolbetuximab (DB15118)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: zolbetuximab + EOX (800 mg/m2 loading dose, then 600 mg/m2 Q3W)
Trial: 33610734
Drug: zolbetuximab +
RxNorm normalized name: Zolbetuximab
DrugBank: Zolbetuximab (DB15118)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: zolbetuximab + EOX (1000 mg/m2 Q3W)
Trial: 32120445
Drug: Oxytocin infusion
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin infusion administered immediately after incision of the visceral peritoneum (Group I)
Trial: 32120445
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Oxytocin infusion administered immediately after clamping the umbilical cord, Group II)
Trial: 32120445
Drug: Oxytocin infusion
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin infusion (Group I)
Trial: 34496448
Drug: 0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg/kg esketamine (SK0)
Trial: 32408905
Drug: Anthracycline-free chemotherapy
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthracycline-free chemotherapy regimen (6x docetaxel/cyclophosphamide, TC)
Trial: 35400202
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (systolic BP 110-139 mm Hg)
Trial: 39696255
Drug: Daily coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily coffee consumption
Trial: 36333773
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate (MA) plus metformin
Trial: 36333773
Drug: Levonorgestrel-releasing intrauterine
RxNorm normalized name: levonorgestrel Intrauterine System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levonorgestrel-releasing intrauterine device (LNG-IUD) plus metformin
Trial: 35660972
Drug: Pembrolizumab and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pembrolizumab and chemotherapy
Trial: 33386288
Drug: Salvage radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salvage radiation therapy with planning based on prostate-specific membrane antigen positron emission tomography/computed tomography
Trial: 33386288
Drug: Salvage radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salvage radiation therapy without planning based on prostate-specific membrane antigen positron emission tomography/computed tomography
Trial: 32673830
Drug: Accelerated antibiotic
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated antibiotic treatment (2 to 4 weeks)
Trial: 32673830
Drug: Standard‐length antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard‐length antibiotic treatment (4 to 6 weeks)
Trial: 34029682
Drug: Oral ferric
RxNorm normalized name: Ferric Oxide
DrugBank: Ferric oxide (DB11576)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ferric maltol at 30mg twice daily for 16 weeks
Trial: 34029682
Drug: Oral ferric
RxNorm normalized name: Ferric Oxide
DrugBank: Ferric oxide (DB11576)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ferric maltol at 30mg twice daily (continued treatment)
Trial: 33989641
Drug: IV paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV paracetamol
Trial: 35120149
Drug: Neural mobilisation
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neural mobilisation techniques and soft tissue mobilisation techniques for 30 minutes per session, 10 weekly sessions, plus advice to stay active on their activities of daily living, information on physical activity, imaging tests, and sciatica for 5 biweekly sessions lasting 25‐30 minutes.
Trial: 32520870
Drug: Moderate-intensity walking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-intensity walking (low dose: 33.6 kJ·kg body weight per week)
Trial: 32520870
Drug: Moderate-intensity walking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-intensity walking (moderate dose: 58.8 kJ·kg body weight per week)
Trial: 32520870
Drug: Moderate-intensity walking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-intensity walking (moderate dose)
Trial: 32520870
Drug: Moderate-intensity walking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-intensity walking (low dose)
Trial: 36444207
Drug: Dexamethasone 0.4
RxNorm normalized name: dexamethasone 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.4 mg intracanalicular insert (DEX)
Trial: 36444207
Drug: Topical prednisolone
RxNorm normalized name: prednisolone Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical prednisolone acetate (PRED)
Trial: 32634360
Drug: Earned Income
RxNorm normalized name: Lincomed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Earned Income Tax Credit of up to $2,000 (treatment)
Trial: 34519136
Drug: Aspirin, paracetamol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin, paracetamol, and caffeine (APC)
Trial: 32960242
Drug: Prophylactic negative
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic negative pressure wound therapy
Trial: 36501066
Drug: Citrulline 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citrulline 3 g
Trial: 33630662
Drug: Combined memory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined memory treatment (traditional episodic memory therapy + semantic memory-focused therapy)
Trial: 35448469
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g whey protein + 10 g sucrose (W‐S‐group)
Trial: 35448469
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g whey protein (W‐group)
Trial: 34610541
Drug: Preoperative methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative methylprednisolone (40 mg or 120 mg)
Trial: 32272030
Drug: Guideline-based physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline-based physical therapy plus dry needling
Trial: 32272030
Drug: Guideline-based physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline-based physical therapy
Trial: 34157188
Drug: Elemental diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elemental diet therapy (EDT) using an amino acid‐based formula
Trial: 35830201
Drug: SOC plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SOC plus arbidol tablets (200 mg three times a day for 14 days)
Trial: 35830201
Drug: SOC plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SOC plus arbidol tablets
Trial: 32048107
Drug: bezlotoxumab 10
RxNorm normalized name: bezlotoxumab 1000 MG in 40 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bezlotoxumab 10 mg/kg
Trial: 33180100
Drug: Preoperative radiotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative radiotherapy regimen of 36 Gy in once-daily 2-Gy fractions
Trial: 39520655
Drug: Cariprazine 1.5
RxNorm normalized name: cariprazine 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cariprazine 1.5 mg/day
Trial: 39520655
Drug: Cariprazine 3
RxNorm normalized name: cariprazine 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cariprazine 3 mg/day
Trial: 35836691
Drug: Increased raw
RxNorm normalized name: raw sugar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased raw vegetable intake through seminars and intensive coaching weekly
Trial: 34784301
Drug: Dialysis treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysis treatment
Trial: 35876109
Drug: 2,4-D herbicide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2,4-D herbicide at a dose of 2.04 g a.e. ha-1
Trial: 35876109
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of 2,4-D applied at tillering stage
Trial: 35876109
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of 2,4-D
Trial: 34333788
Drug: Intragastric balloon
RxNorm normalized name: CATHETER,BALLOON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intragastric balloon therapy
Trial: 32873473
Drug: Ceftriaxone monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone monotherapy
Trial: 36202942
Drug: High-dose corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose corticosteroid pulse therapy
Trial: 32651286
Drug: Laquinimod 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laquinimod 1.5 mg
Trial: 35491679
Drug: Citalopram 20
RxNorm normalized name: citalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 20 mg oral dose
Trial: 33884609
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (SS) in PR group
Trial: 33884609
Drug: Dexmedetomidine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (0.5 mcg/kg/h) in substudy 2
Trial: 33884609
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (SS) in substudy 2
Trial: 32739974
Drug: Valaciclovir at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir at a dose of 8g/day
Trial: 33367869
Drug: Cholecalciferol 3000
RxNorm normalized name: Cholecalciferol 3000 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 3000 IU daily
Trial: 33367869
Drug: Cholecalciferol 25,000
RxNorm normalized name: CHOLECALCIFEROL 25,000UNIT CAP,ORAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 25,000 IU weekly
Trial: 33367869
Drug: Cholecalciferol 100,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 100,000 IU monthly
Trial: 33367869
Drug: Cholecalciferol 1000
RxNorm normalized name: cholecalciferol 1000 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 1000 IU daily (maintenance course)
Trial: 32563846
Drug: Buprenorphine-naloxone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine-naloxone treatment
Trial: 34724895
Drug: Medication reviews
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication reviews during hospitalisation
Trial: 34672898
Drug: Cangrelor (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cangrelor (intravenous P2Y12 receptor antagonist) as a bridging therapy
Trial: 32959922
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg rivaroxaban
Trial: 35930750
Drug: Vemurafenib monotherapy
RxNorm normalized name: Vemurafenib
DrugBank: Vemurafenib (DB08881)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vemurafenib monotherapy
Trial: 34872568
Drug: Gonadotropin‐releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gonadotropin‐releasing hormone agonist (GnRHa)
Trial: 35417485
Drug: Monthly issue-focused
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly issue-focused counseling (for non-responders)
Trial: 33199423
Drug: Micronutrient supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronutrient supplement containing 0.8 mg of folic acid
Trial: 33199423
Drug: Micronutrient supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronutrient supplement without folic acid
Trial: 34411291
Drug: Nd:YAG laser-assisted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nd:YAG laser-assisted periodontal therapy (3 W, 100 μs, 20 Hz; 4 W, 600 μs, 20 Hz)
Trial: 36314174
Drug: Intranasal GM‐CSF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal GM‐CSF administration
Trial: 33032885
Drug: Finger Kazoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finger Kazoo Intensive Short-Term Vocal Therapy
Trial: 35871638
Drug: Low-dose endotoxin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose endotoxin (0.8 ng/kg of body weight)
Trial: 35005013
Drug: morphine
RxNorm normalized name: Morphine
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: morphine
Trial: 36317757
Drug: Reference drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference drug (trastuzumab)
Trial: 36317757
Drug: Test drug
RxNorm normalized name: URINE TEST DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test drug (biosimilar)
Trial: 34880026
Drug: Cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioural therapy (CBT) - seven sessions focused on expectancy management, cognitions regarding pain, and emotional and behavioural impact of pain
Trial: 34611418
Drug: Super bioavailable
RxNorm normalized name: Super Spot Remover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Super bioavailable itraconazole (SBITZ) capsules
Trial: 34611418
Drug: Conventional itraconazole
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional itraconazole (CITZ) capsules
Trial: 32512782
Drug: Longvida© (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Longvida© (400 mg daily containing 80 mg curcumin)
Trial: 34125632
Drug: Both tablets
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both tablets
Trial: 35691326
Drug: Short treatment
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short treatment group
Trial: 33140267
Drug: Diode laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diode laser (810 nm, 1.0 W, CW, irradiation time 20 s for 3 applications) once daily for 3 days
Trial: 33325562
Drug: Acarbose (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (1 x 50 mg, 2 x 50 mg, 3 x 50 mg)
Trial: 34988583
Drug: Music Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music Therapy (MT) - 3 sessions per week, parent-led, infant-directed singing supported by a music therapist; mean of 10 sessions (SD 5.95), with 83% receiving at least 6 sessions.
Trial: 34988583
Drug: Music Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music Therapy (MT) - 3 sessions per week, parent-led, infant-directed singing supported by a music therapist.
Trial: 34988583
Drug: Standard Care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Care (C) - control group receiving usual care without music therapy.
Trial: 34554243
Drug: Canakinumab 150
RxNorm normalized name: canakinumab 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canakinumab 150 or 300 mg every 4 or 8 weeks
Trial: 32264919
Drug: Upfront radical
RxNorm normalized name: Campsis radicans flower extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upfront radical surgery with total mesorectal excision (TME) followed by adjuvant FOLFOX chemotherapy
Trial: 32264919
Drug: Preoperative chemoradiotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemoradiotherapy (PCRT) followed by TME and adjuvant chemotherapy
Trial: 33796907
Drug: IV nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV nicotine (0.0125, 0.025, 0.05, 0.1, or 0.2 mg nicotine/70 kg bodyweight)
Trial: 35254839
Drug: IV nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV nicotine (0.2 mg)
Trial: 32944971
Drug: Group acceptance
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group acceptance and commitment therapy for Psychosis (G‐ACTp) delivered by trained staff and service-user experts, comprising four sessions over weeks 1-4 and two booster sessions at weeks 10 and 12.
Trial: 32944971
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (delayed G‐ACTp after 12 weeks).
Trial: 34965950
Drug: 2 weeks
RxNorm normalized name: Rykindo, 25 mg/2 weeks intramuscular powder for injection, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 weeks of aromatase inhibitors (AI)
Trial: 32471908
Drug: Lixisenatide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lixisenatide (20 μg subcutaneously daily)
Trial: 35841410
Drug: RAM +
RxNorm normalized name: Ramipril
DrugBank: Ramipril (DB00178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: RAM + ERL (ramucirumab 10 mg/kg every 2 weeks with erlotinib 150 mg/day)
Trial: 32725073
Drug: Liberal fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberal fluid therapy